SIGHT SCIENCES INC's ticker is and the CUSIP is 82657M105. A total of 70 filers reported holding SIGHT SCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,903,380 | -65.5% | 1,455,009 | -15.2% | 0.16% | -60.4% |
| Q2 2023 | $14,210,169 | +27.1% | 1,716,204 | +34.2% | 0.41% | +37.1% |
| Q1 2023 | $11,178,993 | -24.3% | 1,279,061 | +5.7% | 0.30% | -23.4% |
| Q4 2022 | $14,770,486 | +175.8% | 1,209,704 | +43.4% | 0.39% | +181.4% |
| Q3 2022 | $5,356,000 | +0.1% | 843,611 | +41.8% | 0.14% | +12.0% |
| Q2 2022 | $5,349,000 | -0.3% | 595,051 | +28.2% | 0.12% | +135.8% |
| Q1 2022 | $5,367,000 | -48.7% | 464,281 | -22.1% | 0.05% | -39.8% |
| Q4 2021 | $10,466,000 | +35.5% | 595,724 | +75.0% | 0.09% | +79.6% |
| Q3 2021 | $7,725,000 | – | 340,319 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 4,776,232 | $42,938,000 | 60.33% |
| Sio Capital Management, LLC | 724,944 | $6,517,000 | 2.45% |
| D1 Capital Partners L.P. | 5,852,036 | $52,610,000 | 1.25% |
| PFM Health Sciences, LP | 776,281 | $6,979,000 | 0.27% |
| RTW INVESTMENTS, LP | 997,099 | $8,964,000 | 0.23% |
| ArrowMark Colorado Holdings LLC | 1,587,305 | $14,270,000 | 0.16% |
| Jackson Square Partners, LLC | 595,051 | $5,349,000 | 0.12% |
| Atom Investors LP | 11,181 | $101,000 | 0.04% |
| Bellevue Group AG | 294,606 | $2,649,000 | 0.04% |
| Orbimed Advisors | 200,000 | $1,798,000 | 0.03% |